Skip to content

News & Events

Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC)

CRITERIUM, Inc. CRO’s ATOMIC PI Leora Horn, MD, Highlighted in ASCOPOST Article
ATOMIC Investigator, Leora Horn, MD, Director of Clinical Research at Vanderbilt University's Ingram Cancer Center, was highlighted in a recent biographical article by the ASCOPOST about her "Journey to a Career in Oncology..." that has taken her from Johannesburg, South Africa to Toronto, Canada to Kentucky.
CRITERIUM, Inc. CRO’s ATOMIC PI’s Co-Author on Medicine Matters
Two ATOMIC Investigators, Natasha B. Leighl, MD, MMSc, FRCPC, and Stephen V. Liu, MD, co-authored an article published online in Medicine Matters outlining how "immunotherapy has forever changed the management of non-small cell lung cancer (NSCLC)."
CRITERIUM, Inc. CRO’s Two Consortia Directors Receive Promotions, Tenure at UCD
Criterium, Inc., a full-service CRO is pleased to announce the promotions of our two newest consortia directors, Drs D. Ross Camidge and Peter Kabos, both from the University of Colorado. Dr Camidge, Director for the ATOMIC Consortia for Thoracic and Lung Cancers, was recently promoted from his current position of Associate Professor, Division of Medical Oncology to "Professor with Tenure". Dr Kabos, Director for the ABRCC Consortia for Breast Cancer, was recently promoted from his current position of Assistant Professor, Division of Medical Oncology to "Associate Professor".
CRITERIUM, Inc. Announces the Formation of Two New Oncology Consortia
Criterium, Inc., a full service global CRO is pleased to announce the formation of its two new oncology consortia: ATOMIC (The Academic Thoracic Oncology Medical Investigator’s Consortium) focusing on Thoracic and Lung Cancers, and ABRCC (The Academic Breast Cancer Consortium), dedicated to Breast Cancer research.
CRITERIUM, Inc. CRO’s ATOMIC Presenters Take the Stage at the IASLC 19th WCLC Conference
At the 19th IASLC World Conference on Lung Cancer in Toronto, Canada, the top 5 abstracts were presented in the Presidential Plenary Session on Tuesday Sept 25th. Out of the 5 presentations, two were presented by ATOMIC members (Stephen Liu, MD, on Impower 133 and Dr. Ross Camidge, MD, PhD, on ALTA-1L) each of which were supported with an associated synchronous New England of Journal of Medicine publication